CoChat

Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon

Open access

The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.

Abstract

Background: Malaria in Brazil represents one of the highest percentages of Latin America cases, where approximately 84% of infections are attributed to Plasmodium ( P . ) vivax . Despite the high incidence, many aspects of gestational malaria resulting from P . vivax infections remain poorly studied. As such, we aimed to evaluate the consequences of P . vivax infections during gestation on the health of mothers and their neonates in an endemic area of the Amazon. Methods and findings: We have conducted an observational cohort study in Brazilian Amazon between January 2013 and April 2015. 600 pregnant women were enrolled and followed until delivery. After applying exclusion criteria, 329 mother-child pairs were included in the analysis. Clinical data regarding maternal infection, newborn’s anthropometric measures, placental histopathological characteristics, and angiogenic and inflammatory factors were evaluated. The presence of plasma IgG against the P . vivax (Pv) MSP1 19 protein was used as marker of exposure and possible associations with pregnancy outcomes were analyzed. Multivariate logistic regression analysis revealed that P . vivax infections during the first trimester of pregnancy are associated with adverse gestational outcomes such as premature birth (adjusted odds ratio [aOR] 8.12, 95% confidence interval [95%CI] 2.69–24.54, p < 0.0001) and reduced head circumference (aOR 3.58, 95%CI 1.29–9.97, p = 0.01). Histopathology analysis showed marked differences between placentas from P . vivax -infected and non-infected pregnant women, especially regarding placental monocytes infiltrate. Placental levels of vasomodulatory factors such as angiopoietin-2 (ANG-2) and complement proteins such as C5a were also altered at delivery. Plasma levels of anti-PvMSP1 19 IgG in infected pregnant women were shown to be a reliable exposure marker; yet, with no association with improved pregnancy outcomes. Conclusions: This study indicates that P . vivax malaria during the first trimester of pregnancy represents a higher likelihood of subsequent poor pregnancy outcomes associated with marked placental histologic modification and angiogenic/inflammatory imbalance. Additionally, our findings support the idea that antibodies against PvMSP1 19 are not protective against poor pregnancy outcomes induced by P . vivax infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pntd.0009390

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Description of study participants and definitions. (A) Flow chart detailing exclusion criteria applied prior data analysis; (B) Definitions of pregnancy partitions used in the report. Mixed infection–P. vivax and P. falciparum infections occurring at the same or different times during pregnancy; w—weeks; d—days.
Fig 1 Description of study participants and definitions. (A) Flow chart detailing exclusion criteria applied prior data analysis; (B) Definitions of pregnancy partitions used in the report. Mixed infection–P. vivax and P. falciparum infections occurring at the same or different times during pregnancy; w—weeks; d—days.CC BY · PubMed Central
Fig 2 Association between adverse pregnancy outcomes and P. vivax infections according to the trimester of first infection. Forest plot of odds ratios of adverse events in newborns from women infected during pregnancy compared with newborns from non-infected women is shown. n/N—number of events by total number of individuals in each group; aOdds Ratio—adjusted Odds Ratio; CI—confidence interval; tri—gestational trimester. Odds ratios were adjusted (aOR) for maternal age, gravidity status, residence, education level and occupation. Preterm birth–birth < 37th week of gestation; Low birth weight–birth weight < 2500 g; Term low birth weight–birth weight < 2500 g from 37th week of gestation; Small for gestational age, Reduced head circumference and Reduced body length–birth weight, head circumference and length (respectively) < 10th centile for sex-specific gestational age. P-values were estimated through multiple logistic regression methods.
Fig 2 Association between adverse pregnancy outcomes and P. vivax infections according to the trimester of first infection. Forest plot of odds ratios of adverse events in newborns from women infected during pregnancy compared with newborns from non-infected women is shown. n/N—number of events by total number of individuals in each group; aOdds Ratio—adjusted Odds Ratio; CI—confidence interval; tri—gestational trimester. Odds ratios were adjusted (aOR) for maternal age, gravidity status, residence, education level and occupation. Preterm birth–birth < 37th week of gestation; Low birth weight–birth weight < 2500 g; Term low birth weight–birth weight < 2500 g from 37th week of gestation; Small for gestational age, Reduced head circumference and Reduced body length–birth weight, head circumference and length (respectively) < 10th centile for sex-specific gestational age. P-values were estimated through multiple logistic regression methods.CC BY · PubMed Central
Fig 3 Anthropometric measurements of newborns according to maternal infection and trimester of first infection. (A) Newborn weight; (B) Head circumference; (C) Chest circumference; and, (D) Length. NI–non-infected (N = 160–169); Pv–P. vivax-infected pregnant women (N = 130–150); Pv-1st tri–P. vivax infection 1st trimester (N = 38–46); Pv-2nd tri–P. vivax infection 2nd trimester (N = 43–54); Pv-3rd tri–P. vivax infection 3rd trimester (N = 49–50). Weight is given in grams (g). Head and chest circumferences, and body length are informed in centimeters (cm). Data are represented as Tukey boxplots, with the bottom and top of each box representing the first and third quartiles; the line inside the box is the median, and the whiskers represent the lowest and the highest data within 1.5 IQR of the first and upper quartiles; and the circles, outliers. Differences between groups were determined by multiple liner regression (adjusted for maternal age, gravidity status, residence, education level, and occupation).
Fig 3 Anthropometric measurements of newborns according to maternal infection and trimester of first infection. (A) Newborn weight; (B) Head circumference; (C) Chest circumference; and, (D) Length. NI–non-infected (N = 160–169); Pv–P. vivax-infected pregnant women (N = 130–150); Pv-1st tri–P. vivax infection 1st trimester (N = 38–46); Pv-2nd tri–P. vivax infection 2nd trimester (N = 43–54); Pv-3rd tri–P. vivax infection 3rd trimester (N = 49–50). Weight is given in grams (g). Head and chest circumferences, and body length are informed in centimeters (cm). Data are represented as Tukey boxplots, with the bottom and top of each box representing the first and third quartiles; the line inside the box is the median, and the whiskers represent the lowest and the highest data within 1.5 IQR of the first and upper quartiles; and the circles, outliers. Differences between groups were determined by multiple liner regression (adjusted for maternal age, gravidity status, residence, education level, and occupation).CC BY · PubMed Central
Fig 4 Evaluation of placental histological parameters according to maternal infection and trimester of first infection. (A) Syncytial nuclear aggregates; (B) Fibrin deposition score; (C) Monocytes infiltrate (CD68+); (D) Leukocytes infiltrate (CD45+). Histologic parameters were evaluated by microscopy through H&E (syncytial nuclear aggregates and fibrin deposition) or immunohistochemistry (monocytes and leukocytes). NI–non-infected (N = 153–155); Pv–P. vivax-infected pregnant women (N = 118–128); Pv-1st tri–P. vivax infection 1st trimester (N = 33–37); Pv-2nd tri–P. vivax infection 2nd trimester (N = 42–44); Pv-3rd tri–P. vivax infection 3rd trimester (N = 43–47). Data are represented as Tukey boxplots, with the bottom and top of each box representing the first and third quartiles; the line inside the box is the median, and the whiskers represent the lowest and the highest data within 1.5 IQR of the first and upper quartiles; and the circles, outliers. Differences between groups were determined by multiple liner regression (adjusted for maternal age, gravidity status, residence, education level, and occupation).
Fig 4 Evaluation of placental histological parameters according to maternal infection and trimester of first infection. (A) Syncytial nuclear aggregates; (B) Fibrin deposition score; (C) Monocytes infiltrate (CD68+); (D) Leukocytes infiltrate (CD45+). Histologic parameters were evaluated by microscopy through H&E (syncytial nuclear aggregates and fibrin deposition) or immunohistochemistry (monocytes and leukocytes). NI–non-infected (N = 153–155); Pv–P. vivax-infected pregnant women (N = 118–128); Pv-1st tri–P. vivax infection 1st trimester (N = 33–37); Pv-2nd tri–P. vivax infection 2nd trimester (N = 42–44); Pv-3rd tri–P. vivax infection 3rd trimester (N = 43–47). Data are represented as Tukey boxplots, with the bottom and top of each box representing the first and third quartiles; the line inside the box is the median, and the whiskers represent the lowest and the highest data within 1.5 IQR of the first and upper quartiles; and the circles, outliers. Differences between groups were determined by multiple liner regression (adjusted for maternal age, gravidity status, residence, education level, and occupation).CC BY · PubMed Central
Fig 5 Anthropometric measurements of newborn, according to previous exposure to P. vivax (PvMSP1). (A) Antibody profile among non-infected and P. vivax-infected pregnant women; (B) Forest plot of odds ratios of adverse pregnancy outcomes in infected women with anti-PvMSP1 IgG compared with infected women without anti-PvMSP1 IgG; (C) Newborn weight; (D) Head circumference; (E) Chest circumference; and, (F) Length. NI-PvMSP1Ab-—non-infected non-exposed (N = 106–112); NI- PvMSP1Ab+—non-infected exposed (N = 54–58); Pv- PvMSP1Ab-—P. vivax-infected non-exposed (N = 19); Pv- PvMSP1Ab+—P. vivax-infected exposed (N = 80–95). PvMSP1- Plasmodium vivax merozoite surface protein 1; Ab—Antibody; LBW—low birth weight; SGA—small for gestational age; HC—head circumference. RI—Reactivity indices were calculated as the ratio between each test sample’s corrected absorbance values and a cut-off value for antigen, corresponding to the average corrected absorbance of samples from 10 malaria-naïve blood donors plus 3 standard deviations. Weight in grams (g). Head and chest circumferences, and body length in centimeters (cm). Data are represented as Tukey boxplots, with the bottom and top of each box representing the first and third quartiles; the line inside the box is the median, and the whiskers represent the lowest and the highest data within 1.5 IQR of the first and upper quartiles; and the circles, outliers. Odds ratios were adjusted (aOR) for maternal age, gravidity status, residence, education level and occupation using multiple logistic regression. Differences among the groups were determined by multiple linear regression (adjusted for maternal age, gravidity status, residence, education level and occupation).
Fig 5 Anthropometric measurements of newborn, according to previous exposure to P. vivax (PvMSP1). (A) Antibody profile among non-infected and P. vivax-infected pregnant women; (B) Forest plot of odds ratios of adverse pregnancy outcomes in infected women with anti-PvMSP1 IgG compared with infected women without anti-PvMSP1 IgG; (C) Newborn weight; (D) Head circumference; (E) Chest circumference; and, (F) Length. NI-PvMSP1Ab-—non-infected non-exposed (N = 106–112); NI- PvMSP1Ab+—non-infected exposed (N = 54–58); Pv- PvMSP1Ab-—P. vivax-infected non-exposed (N = 19); Pv- PvMSP1Ab+—P. vivax-infected exposed (N = 80–95). PvMSP1- Plasmodium vivax merozoite surface protein 1; Ab—Antibody; LBW—low birth weight; SGA—small for gestational age; HC—head circumference. RI—Reactivity indices were calculated as the ratio between each test sample’s corrected absorbance values and a cut-off value for antigen, corresponding to the average corrected absorbance of samples from 10 malaria-naïve blood donors plus 3 standard deviations. Weight in grams (g). Head and chest circumferences, and body length in centimeters (cm). Data are represented as Tukey boxplots, with the bottom and top of each box representing the first and third quartiles; the line inside the box is the median, and the whiskers represent the lowest and the highest data within 1.5 IQR of the first and upper quartiles; and the circles, outliers. Odds ratios were adjusted (aOR) for maternal age, gravidity status, residence, education level and occupation using multiple logistic regression. Differences among the groups were determined by multiple linear regression (adjusted for maternal age, gravidity status, residence, education level and occupation).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Research works printed but not linked: 2

  1. Brazil. Ministry of Health. Secretariat of Health Surveillance. Department of Epidemiological Surveillance, 2010, Malaria’s treatment in Brazil practical guide. Brazilian Ministry of Health, Departamento de Vigilância Epidemiológica—Secretaria de Vigilância em Saúde
  2. WHO, 2015, Guidelines for the treatment of malaria

Cited by

See all 46

Metadata

Authors
Dombrowski, J. G., Barateiro, A., Peixoto, E. P. M., Barros, A. B. C. D. S., Souza, R. M. D., Clark, T. G., Campino, S., Wrenger, C., Wunderlich, G., Palmisano, G., Epiphanio, S., Gonçalves, L. A., & Marinho, C. R. F.
Affiliations
  • Universidade de São Paulo (BR)
  • Instituto Gulbenkian de Ciência (PT)
  • Universidade Federal do Acre (BR)
  • London School of Hygiene & Tropical Medicine (GB)
Corresponding author
  • Dombrowski, Jamille Gregório
  • Barateiro, André
  • Peixoto, Erika Paula Machado
  • Barros, André Boler Cláudio da Silva
  • Souza, Rodrigo Medeiros de
  • Clark, Taane Gregory
  • Campino, Susana
  • Wrenger, Carsten
  • Wunderlich, Gerhard
  • Palmisano, Giuseppe
  • Gonçalves, Lígia Antunes
Venue
PLOS Neglected Tropical Diseases
Published
2021-04-29
Volume
15
Issue
4
Pages
e0009390
ISSN
  • 1935-2727 (ISSN-L)
  • 1935-2735
OpenAlex
W3158909516
Cited by
42
References
77
Citations by year
2026: 2 · 2025: 8 · 2024: 13 · 2023: 6 · 2022: 8 · 2021: 5
FWCI
6.92
Type
journal article
Language
en
Open access
Locations
  • PLoS neglected tropical diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/20468-0; 2020/06747-4, 2017/05782-8, 2015/26722-8; 2017/03966-4, 2017/24267-7, 2018/18257-1; 2018/15549-1; 2020/04923-0, 2019/12068-5, 2017/03939-7)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (409216/2018-6)
  • Medical Research Council United Kingdom (MR/M01360X/1; MR/N010469/1; MR/R025576/1; MR/R020973/1, MR/M01360X/1; MR/R025576/1; MR/R020973/1)
  • Fundação para a Ciência e a Tecnologia (PD/BD/138900/2018)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
Keywords
Plasmodium vivax, malaria in pregnancy, adverse pregnancy outcomes, preterm birth, fetal head circumference, placental pathology, angiopoietin-2, C5a, angiogenic imbalance, first trimester, maternal and fetal health, Brazilian Amazon
MeSH terms
Adolescent, Adult, Antigens, Protozoan, Brazil, Female, Humans, Immunoglobulin G, Infant, Newborn, Placenta, Plasmodium vivax, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Pregnancy Trimester, First, Prospective Studies, Multivariate Analysis, Logistic Models, Malaria, Falciparum, Malaria, Vivax, Premature Birth, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon. https://app.cochat.ai/papers/10.1371/journal.pntd.0009390
The paper
Dombrowski, J. G., Barateiro, A., Peixoto, E. P. M., Barros, A. B. C. D. S., Souza, R. M. D., Clark, T. G., Campino, S., Wrenger, C., Wunderlich, G., Palmisano, G., Epiphanio, S., Gonçalves, L. A., & Marinho, C. R. F. (2021). Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0009390

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.